Wednesday, April 30, 2008
NevBio Goes to Washington DC
Biotechnology Industry Organization (BIO) sponsored seven members of the Nevada Biotechnology and Bioscience Consortium to be in Washington DC on April 15th and 16th to attend several briefings on issues concerning the industry and to provide an opportunity to discuss biotechnology with the Nevada Congressional Delegation
The industry is concerned about proposed changes in patenting, the need to increase funding to the National Institute of Health (NIH) and the Federal Drug Administration (FDA), opening up the Small Business Innovative Research (SBIR) programs to companies that have taken venture capital funding and to provide broader support of Biofuels initiatives.
The Nevada Biotechnology & Bioscience Consortium group included: John Laub, Nev Bio Executive Director; Linda Rubinson, Nev Bio Development Director; Ron Yasbin, Dean of the College of Sciences at UNLV; Carl Reiber, Associate Dean of the College of Sciences at UNLV; Oliver Hemmers, Director of Strategic Energy Programs at UNLV; Jennifer Von Tobel, Executive Director of the Von Tobel Bio-Medical Institute and Trish Williamson, Marketing Director of the Von Tobel Bio-Medical Institute.
The delegation met with the following:
Senator Reid’s office included Jason Unger, Brittany Blanchard, Neil Kornze, Carolyn Gluck, Michael Castellano and Mark Wetjen.
Senator John Ensign’s office included Jason D. Mulvihill, Andrew Shaw, Brooke Allmon and John Lopez
Congresswoman’s Shelley Berkeley’s office included Congresswoman Shelly Berkeley, Matthew R. Coffron and Jeremy Kadden.
Congressman’s Jon Porter office included Congressman Jon Porter, Stan Olsen and John Minn.
Congressman Dean Heller office included Congressman Dean Heller, Leeann Walker and Stewart "Mac" Bybee.